Details for Patent: 12,377,176
Which drugs does patent 12,377,176 protect, and when does it expire?
Patent 12,377,176 protects POSLUMA and is included in one NDA.
This patent has eighteen patent family members in twelve countries.
Summary for Patent: 12,377,176
| Title: | Cancer diagnostic imaging agents |
| Abstract: | The present invention relates to a ligand-SIFA-chelator conjugate, comprising, within a single molecule three separate moieties: (a) one or more ligands which are capable of binding to PSMA, (b) a silicon-fluoride acceptor (SIFA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom, and (c) one or more chelating groups, containing a chelated nonradioactive cation. |
| Inventor(s): | Alexander Josef Wurzer, Hans-Jürgen Wester, Matthias Johannes Eiber |
| Assignee: | Technische Universitaet Muenchen Klinikum Rechts Der Isar , Technische Universitaet Muenchen , Klinikum Rechts der Isar der Technischen Universitaet Muenchen |
| Application Number: | US17/427,006 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 12,377,176
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blue Earth | POSLUMA | flotufolastat f-18 gallium | SOLUTION;INTRAVENOUS | 216023-001 | May 25, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,377,176
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020215086 | ⤷ Start Trial | |||
| Australia | 2023208070 | ⤷ Start Trial | |||
| Brazil | 112021015035 | ⤷ Start Trial | |||
| Canada | 3128406 | ⤷ Start Trial | |||
| China | 113573743 | ⤷ Start Trial | |||
| China | 116585494 | ⤷ Start Trial | |||
| Eurasian Patent Organization | 202192045 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
